Histamine Completed Phase 4 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01347996Maintenance Therapy With CepleneĀ® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia